Information About CyberLex
Recent Posts
Below is a preview of the five most recent posts from the blog CyberLex. To read these posts in their entirely or subscribe to future updates from this blog, please visit their website!
- Special Committee Begins Consultations on Changes to BC’s Personal Information Protection Act
On February 18, 2020, the Legislative Assembly of British Columbia appointed a Special Committee to conduct a review of British Columbia’s private and not-for-profit sector privacy legislation: the Personal Information Protection Act (“PIPA”). The Special Committee will be holding public hearings vi … Read more »
- Tactical use of threatening cease and desist letters discouraged by the Court
This week the Federal Court published a January decision, Fluid Energy Group Ltd v Exaltexx Inc, 2020 FC 81, in which it granted an interlocutory injunction enjoining the plaintiff from sending “very threatening” cease and desist letters to third parties who traded with the defendant. The letters al … Read more »
- To Invent is Human: U.S. Patent and Trademark Office Rejects AI System as an Inventor
The United States Patent and Trademark Office (USPTO) issued a decision on April 22, 2020 in which it concluded that an artificial intelligence (AI) system could not be recognized as an inventor in a US patent application. In doing so, it has ruled that only “natural persons” are eligible as invent … Read more »
- US FTC Publishes Guidance on Using Artificial Intelligence and Algorithms
On April 8, 2020, the US Federal Trade Commission (“FTC”) published a business blog, titled “Using Artificial Intelligence and Algorithms” (the “FTC Blog”). The FTC Blog suggests that, while the use of AI technologies and algorithms has immense potential for improving welfare and productivity, it al … Read more »
- First Trial Decision Under Canada’s Amended Patented Medicines (Notice of Compliance) Regulations Offers Guidance on Key Issues
Earlier this week, the Federal Court of Canada publicly released Amgen Inc. v. Pfizer Canada ULC, 2020 FC 522, the first trial decision under the amended Patented Medicines (Notice of Compliance) Regulations (“PM(NOC) Regulations”). Prior to 2017, proceedings under Canada’s drug patent linkage legis … Read more »